Michael S Poirier Net Worth & Insider Trades
Michael S Poirier - Chairman and CEO, Qualigen Therapeutics, Inc
What is Michael S Poirier's Net Worth?
The current estimated net worth of Qualigen Therapeutics, Inc's Chairman and CEO, Michael S Poirier, is estimated to be about $204.72K . Michael S Poirier owns about 210,207 units of Qualigen Therapeutics, Inc common stock. In the last 2 years at Qualigen Therapeutics, Inc, Michael S Poirier has sold an estimated value of $0 worth.
What is Michael S Poirier's Past Insider Trading?
Michael S Poirier's largest purchase order was 11,005 units , worth over $19.81K on April 21, 2021. In total, Michael S Poirier has made about 5 transactions over 2 years of their time at Qualigen Therapeutics, Inc. Michael S Poirier usually trades in June, with the busiest year in 2020 and 2022. The most recent transaction was a purchase order of 30,000 units , worth over $17.1K on June 22, 2022.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Michael S Poirier
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Michael S Poirier's' Mailing Address?
- Mailing address is 2042 Corte del Nogal Suite B Carlsbad CA 92011 CA
What are Qualigen Therapeutics, Inc's Past Insider Trades?
Qualigen Therapeutics, Inc's most recent insider trade came on June 22, 2022 by Michael S Poirier who bought 30,000 units worth $17.1K . In the last 2 years, insiders at Qualigen Therapeutics, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in August, with the busiest year in 2020. The most active traders at the company are Amy S Broidrick, President/CSO, Kurt H Kruger, Director, and Michael S Poirier, Chairman and CEO .
Qualigen Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |